These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 10351162)

  • 21. Quality assurance of blood components prepared in the blood transfusion center/blood bank.
    Vox Sang; 1994; 67(1):99-111. PubMed ID: 7975467
    [No Abstract]   [Full Text] [Related]  

  • 22. Low level leucocyte counting: a critical variable in the validation of leucodepleted blood transfusion components as highlighted by an external quality assessment study.
    Barnett D; Goodfellow K; Ginnever J; Granger V; Whitby L; Reilly JT
    Clin Lab Haematol; 2001 Feb; 23(1):43-51. PubMed ID: 11422230
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A national quality assessment scheme for counting residual leucocytes in unfixed leucodepleted products: the effect of standardisation and 48 hour storage.
    Krailadsiri P; Seghatchian J; Rigsby P; Bukasa A; Bashir S
    Transfus Apher Sci; 2002 Feb; 26(1):73-81. PubMed ID: 11931380
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [State and perspectives of the French haemovigilance system. Presentation of the data collected over 9 years].
    David B
    Transfus Clin Biol; 2003 Jun; 10(3):131-9. PubMed ID: 12798845
    [No Abstract]   [Full Text] [Related]  

  • 25. Segments from red blood cell units should not be used for quality testing.
    Kurach JD; Hansen AL; Turner TR; Jenkins C; Acker JP
    Transfusion; 2014 Feb; 54(2):451-5. PubMed ID: 23834158
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The quality of blood products in Mississippi takes another leap forward.
    Jett PL
    J Miss State Med Assoc; 1999 Nov; 40(11):390-1. PubMed ID: 10568090
    [No Abstract]   [Full Text] [Related]  

  • 27. Quality requirements and quality assurance of leukocyte-depleted blood components.
    Myllylä G
    Curr Stud Hematol Blood Transfus; 1994; (60):111-22. PubMed ID: 8088164
    [No Abstract]   [Full Text] [Related]  

  • 28. The development of a national standardized approach for the enumeration of residual leucocytes in blood components.
    Cardigan R; Phipps A; Seghatchian J; Bashir S; Aynsley S; Beckman N; Barnett D; Reilly JT; Williamson LM
    Vox Sang; 2002 Aug; 83(2):100-9. PubMed ID: 12201839
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Potential clinical benefits and cost savings of universal leucocyte-depletion of blood components.
    Murphy MF
    Transfus Sci; 1998 Dec; 19(4):343-6. PubMed ID: 10351149
    [No Abstract]   [Full Text] [Related]  

  • 30. Value of central analysis of leucocyte depletion quality control data within the National Blood Service, England.
    Beckman N; Cardigan R; Wallington T; Williamson LM
    Vox Sang; 2002 Aug; 83(2):110-8. PubMed ID: 12201840
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A model for blood components processing.
    Lowalekar H; Ravichandran N
    Transfusion; 2011 Jul; 51(7 Pt 2):1624-34. PubMed ID: 21736584
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Transfusion medicine issues in the practice of anesthesiology.
    Robblee JA; Crosby E
    Transfus Med Rev; 1995 Jan; 9(1):60-78. PubMed ID: 7719039
    [No Abstract]   [Full Text] [Related]  

  • 33. Implementation of an effective program for quality assurance and quality control in living cell therapy: a 2-year experience with autolymphocyte therapy.
    du Moulin GC; Liu V; Osband ME
    Transplant Proc; 1992 Dec; 24(6):2803-8. PubMed ID: 1465947
    [No Abstract]   [Full Text] [Related]  

  • 34. [Audit of labile blood product supplies].
    Cabaud JJ
    Transfus Clin Biol; 2000 Jun; 7 Suppl 1():75s-79s. PubMed ID: 10919230
    [TBL] [Abstract][Full Text] [Related]  

  • 35. EU sets standards for safe blood products.
    Watson R
    BMJ; 2003 Jan; 326(7379):11. PubMed ID: 12511447
    [No Abstract]   [Full Text] [Related]  

  • 36. Quality control of leucocyte-reduced blood components: overestimation of WBC content due to nucleated red blood cells.
    Fischer JC; Moog R; Giers G
    Vox Sang; 2012 Jan; 102(1):79-81. PubMed ID: 21564108
    [TBL] [Abstract][Full Text] [Related]  

  • 37. National French observatory of the quality of blood components for transfusion.
    Chabanel A; Masse M; Begue S;
    Transfus Clin Biol; 2008 Jun; 15(3):85-90. PubMed ID: 18524661
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Update on leucocyte depletion of blood components by filtration.
    Pietersz RN; van der Meer PF; Seghatchian MJ
    Transfus Sci; 1998 Dec; 19(4):321-8. PubMed ID: 10351145
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Quality of transfusion practice beyond the blood transfusion laboratory is essential to prevent ABO-incompatible death.
    Voak D; Chapman JF; Phillips P
    Transfus Med; 2000 Jun; 10(2):95-6. PubMed ID: 10849377
    [No Abstract]   [Full Text] [Related]  

  • 40. Universal WBC reduction.
    Nightingale SD;
    Transfusion; 2001 Oct; 41(10):1306-9. PubMed ID: 11606833
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.